| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0034 | 1 |